SMS Pharmaceuticals Ltd - 532815 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.
SMS Pharma uncovered fraudulent claims for 85,000 physical equity shares belonging to 7 original shareholders. The company lodged a police complaint, and the EOW has registered a case for further investigation into the common modus operandi.
Jun 05 2026 15:42:08
SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
SMS Pharma announced the audio recording of its Analysts/Investors Conference Call, held on May 27, 2026, for Q4 and FY26 financial results is now available. Investors can access the recording on the company's website.
May 27 2026 17:03:18
SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
SMS Pharmaceuticals announced strong FY26 financial results, with PAT rising 48% YoY to Rs.102 crore and revenue increasing 13% to Rs.886.87 crore. The company saw EBITDA margin expand to 19% due to backward integration.
May 23 2026 17:49:06
SMS Pharmaceuticals Ltd - 532815 - Board Meeting Outcome for Approval Of Financial Results For The Fourth Quarter And Year Ended 31St March, 2026
SMS Pharmaceuticals board approved Q4 & FY26 financial results, reporting Q4 cons. revenue of ₹237.95 crore and net profit of ₹32.71 crore. The board also recommended a final dividend of ₹0.40 per share for FY26.
May 22 2026 13:48:02
SMS Pharmaceuticals Limited
SMS Pharmaceuticals board is scheduled to meet on May 22, 2026. The agenda includes the consideration and approval of the company's audited financial results for the year ended March 31, 2026, and a recommendation for a final dividend.
May 16 2026 10:37:07
Read More